Food as Medicine: An RCT to Study the Effect of Home Delivered, Medically Tailored Meals on Patients With Metastatic Cancer

Completed · Not applicable

Conditions studied: Quality of Life

In brief

The purpose of this study is to determine whether medically tailored meals (HDTM) can improve quality of life for patients with metastatic cancer.

Key facts

Study ID

NCT02887235

Run by

NYU Langone Health

People needed

6

Starts

2016-03-01

Expected to finish

2019-08-08

Last updated by the study team

2020-06-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of pathologically confirmed metastatic pancreatic, hepatobiliary, esophageal, or lung cancer, either newly metastatic or metastatic at presentation (M1+) and enrollment within 6 weeks of diagnosis; measurable disease need not be present.
• Pain Score (PS) 0-3
• Age>18
• Both male and female subjects eligible
• All ethnicities eligible
• Access to refrigerator or freezer

You may not qualify if…

• Diagnosis of metastatic cancer no greater than 6 weeks prior to expected study enrollment
• Currently receiving home delivered meals from other sources
• Evidence of any alimentary tract obstruction or other condition preventing oral alimentation
• Requirement for enteral or parenteral nutrition at time of diagnosis
• Incarcerated individuals

Where it is running

• NYU Perlmutter Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.